These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9495601

  • 1. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.
    Smeraldi E.
    J Affect Disord; 1998 Feb; 48(1):47-56. PubMed ID: 9495601
    [Abstract] [Full Text] [Related]

  • 2. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
    Boyer P, Lecrubier Y, Stalla-Bourdillon A, Fleurot O.
    Neuropsychobiology; 1999 Feb; 39(1):25-32. PubMed ID: 9892856
    [Abstract] [Full Text] [Related]

  • 3. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
    Ravizza L.
    J Psychopharmacol; 1999 Feb; 13(3):248-54. PubMed ID: 10512080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
    Cassano GB, Jori MC, AMIMAJOR Group.
    Int Clin Psychopharmacol; 2002 Jan; 17(1):27-32. PubMed ID: 11800503
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia.
    Zanardi R, Smeraldi E.
    Eur Neuropsychopharmacol; 2006 May; 16(4):281-7. PubMed ID: 16316746
    [Abstract] [Full Text] [Related]

  • 7. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A, Mikkelsen H, Delini-Stula A.
    J Psychiatr Res; 1996 May; 30(6):453-8. PubMed ID: 9023788
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
    Rocca P, Marchiaro L, Rasetti R, Rivoira E, Bogetto F.
    Psychiatry Res; 2002 Oct 10; 112(2):145-52. PubMed ID: 12429360
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep 10; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB, Thase ME, EPIC 014 Study Group.
    J Psychiatr Res; 2007 Sep 10; 41(3-4):351-9. PubMed ID: 16165158
    [Abstract] [Full Text] [Related]

  • 16. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
    Wetzel H, Gründer G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schröder J, Rein W, Benkert O.
    Psychopharmacology (Berl); 1998 Jun 10; 137(3):223-32. PubMed ID: 9682999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Controlled efficacy study of fluoxetine in dysthymia.
    Vanelle JM, Attar-Levy D, Poirier MF, Bouhassira M, Blin P, Olié JP.
    Br J Psychiatry; 1997 Apr 10; 170():345-50. PubMed ID: 9246253
    [Abstract] [Full Text] [Related]

  • 20. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.
    Pharmacopsychiatry; 2008 Jan 10; 41(1):24-8. PubMed ID: 18203048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.